Apoptosis, neuroprotection, and retinal ganglion cell death: An overview

International Ophthalmology Clinics

Volumn 41, Issue 1, 2001, Pages 111-130

  Farkas, R H ^a   Grosskreutz, C L ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; FREE RADICAL; GLUCOCORTICOID; GLUTAMIC ACID; GROWTH FACTOR; LAZAROID; METHYLPREDNISOLONE; NIFEDIPINE; NITRATE; NITRIC OXIDE; STEROID; TIRILAZAD;

AGING; ALZHEIMER DISEASE; APOPTOSIS; CELL FUNCTION; CELL SURVIVAL; DRUG MECHANISM; GLAUCOMA; HUMAN; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; OPTIC NERVE DISEASE; OPTIC NERVE INJURY; PATHOGENESIS; PRIORITY JOURNAL; RETINA GANGLION CELL; REVIEW; TREATMENT OUTCOME;

AGING; ALZHEIMER DISEASE; APOPTOSIS; GLAUCOMA; HUMANS; NECROSIS; NEUROPROTECTIVE AGENTS; OPTIC NERVE INJURIES; OPTIC NEURITIS; RETINAL GANGLION CELLS;

EID: 0035157638     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004397-200101000-00011     Document Type: Review

References (140)

1. Mechanisms of photoreceptor death in retinal degenerations. From the cell biology of the 1990s to the ophthalmology of the 21st century?
2. Mechanisms of cell death in the inherited retinal degenerations
3. Apoptosis in ocular disease: A molecular overview
4. Retinal ganglion cell death in glaucoma: The how, the why, and the maybe
5. Neuroprotection of the optic nerve in glaucoma
6. The nerve of glaucoma!
7. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
8. Cell death: The significance of apoptosis
9. Neuronal necrosis and apoptosis: Two distinct events induced by exposure to glutamate or oxidative stress
10. Apoptosis and necrosis: Two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures
11. Glutamate-treated rat cortical neuronal cultures die in a way different from the classical apoptosis induced by staurosporine
12. Detection of higher-order 50- and 10-kbp DNA fragments before apoptotic internucleosomal cleavage after transient cerebral ischemia
13. Increases in DNA lesions and the DNA damage indicator Gadd45 following transient cerebral ischemia
14. DNA damage consistent with apoptosis in transient focal ischaemic neocortex
15. Why neurons die: Cell death in the nervous system
16. Caspases: Enemies within
17. Mitochondria and apoptosis
18. The Bcl-2 protein family: Arbiters of cell survival
19. Bcl-2 functions in an antioxidant pathway to prevent apoptosis
20. Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species
21. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia
22. Retardation of chemical hypoxia-induced necrotic cell death by Bcl-2 and ICE inhibitors: Possible involvement of common mediators in apoptotic and necrotic signal transductions
23. Inhibition of caspase activity induces a switch from apoptosis to necrosis
24. BDNF or IGF-I potentiates free radical-mediated injury in cortical cell cultures
25. Potentiated necrosis of cultured cortical neurons by neurotrophins
26. Protection of retinal ganglion cells from natural and axotomy-induced cell death in neonatal transgenic mice overexpressing bcl-2
27. Inhibition of ICE slows ALS in mice
28. Expression of a dominant negative mutant of interleukin-1 beta converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury
29. Attenuation of transient focal cerebral ischemic injury in transgenic mice expressing a mutant ICE inhibitory protein
30. Suppression of developmental retinal cell death but not of photoreceptor degeneration in Bax-deficient mice
31. Overexpression of Bcl-2 or Bcl-XL transgenes and photoreceptor degeneration
32. Inhibition of human caspases by peptide-based and macromolecular inhibitors
33. Caspases: Key mediators of apoptosis
34. An ICE inhibitor, z-VAD-DCB attenuates ischaemic brain damage in the rat
35. Mitochondrial control of apoptosis
36. Mitochondrial permeability transition triggers lymphocyte apoptosis
37. Experimental therapeutics of neurodegenerative disorders: Unmet needs
38. Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-n-aspartate
39. p53 expression in nitric oxide-induced apoptosis
40. Nitric oxide induces apoptosis in mouse thymocytes
41. Superoxide dismutase delays neuronal apoptosis: A role for reactive oxygen species in programmed neuronal death
42. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen
43. The free radical theory of aging matures
44. Free radicals: Their history and current status in aging and disease
45. HIV-related neuronal injury. Potential therapeutic intervention with calcium channel antagonists and NMDA antagonists
46. Mechanisms of immune injury in multiple sclerosis
47. Nitric oxide and superoxide contribute to motor neuron apoptosis induced by trophic factor deprivation
48. Brain-derived neurotrophic factor promotes survival and blocks nitric oxide synthase expression in adult rat spinal motoneurons after ventral root avulsion
49. Free radical scavenging and inhibition of nitric oxide synthase potentiates the neurotrophic effects of brain-derived neurotrophic factor on axotomized retinal ganglion cells in vivo
50. Nerve growth factor potentiates the oxidative necrosis of striatal cholinergic neurons
51. N-acetyl-n-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro
52. Nitric oxide-mediated death of cultured neonatal retinal ganglion cells: Neuroprotective properties of glutamate and chondroitin sulfate proteoglycan
53. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds
54. Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex
55. Suppression of neuronal apoptosis by Snitrosylation of caspases
56. Redox regulation of apoptosis: Impact of thiol oxidation status on mitochondrial function
57. Control of cell number in the developing mammalian visual system
58. Development of the human retina: Patterns of cell distribution and redistribution in the ganglion cell layer
59. Cell generation, death, and retinal growth in the development of the hamster retinal ganglion cell layer
60. Duration of retinogenesis: Its relationship to retinal organization in two cricetine rodents
61. Chronic glaucoma selectively damages large optic nerve fibers
62. Retinal ganglion cell loss is size dependent in experimental glaucoma
63. Blockade of electrical activity promotes the death of mammalian retinal ganglion cells in culture
64. Early removal of one eye reduces normally occurring cell death in the remaining eye
65. Regulation of axon number in primate optic nerve by prenatal binocular competition
66. Binocular interaction in the fetal cat regulates the size of the ganglion cell population
67. Neonatal retinal ganglion cell cultures of high purity: Effect of superior colliculus on their survival
68. Activity and the control of ganglion cell death in the rat retina
69. Topographic targeting errors in the retinocollicular projection and their elimination by selective ganglion cell death
70. Presynaptic initiation by action potentials of retrograde signals in developing neurons
71. BDNF injected into the superior colliculus reduces developmental retinal ganglion cell death
72. Reduced size of retinal ganglion cell axons and hypomyelination in mice lacking brain-derived neurotrophic factor
73. Major biological effects of neurotrophic factors on retinal ganglion cells in mammals
74. Neurotrophins in the developing and regenerating visual system
75. Prolonged administration of NT-4/5 fails to rescue most axotomized retinal ganglion cells in adult rats
76. Transynaptic degeneration in the visual system
77. Trans-synaptic retrograde degeneration in the visual system of primates
78. Preservation of retinal ganglion cells and normal patterns of retinogeniculate projections in prosimian primates with long-term ablations of striate cortex
79. Therapeutic potential of neurotrophic factors for neurological disorders
80. Aging of the human retina. Differential loss of neurons and retinal pigment epithelial cells
81. Retinal ganglion cells in Alzheimer's disease and aging
82. The effect of age on the nerve fiber population of the human optic nerve
83. The normal human optic nerve. Axon count and axon diameter distribution
84. Histomorphometry of the human optic nerve
85. Human optic nerve fiber count and optic disc size
86. The effect of age on normal human optic nerve fiber number and diameter
87. Differentiating patients with glaucoma from glaucoma suspects and normal subjects by nerve fiber layer assessment with scanning laser polarimetry
88. Variation of nerve fibre layer thickness measurements with age and ethnicity by scanning laser polarimetry
89. Effects of aging on the densities, numbers, and sizes of retinal ganglion cells in rhesus monkey
90. Effects of aging on numbers and sizes of neurons in histochemically defined subregions of monkey striate cortex
91. Aging changes of the rhesus monkey optic nerve
92. Changes in the aging rat retina
93. A morphological and morphometrical study of the retina in aging SAM mice
94. Evidence of cell loss from the rat retina during senescence
95. Myelinated axon number in the optic nerve is unaffected by Alzheimer's disease
96. Retinal pathology in Alzheimer's disease: I. Ganglion cell loss in foveal/parafoveal retina
97. Optic-nerve degeneration in Alzheimer's disease
98. Optic nerve damage in Alzheimer's disease
99. Optic nerve head and nerve fiber layer in Alzheimer's disease
100. Abnormal pattern electroretinogram in Alzheimer's disease: Evidence for retinal ganglion cell degeneration?
101. Abnormal pattern electroretinograms in patients with senile dementia of the Alzheimer type
102. The cellular mechanism underlying neuronal degeneration in glaucoma: Parallels with Alzheimer's disease
103. Traumatic optic neuropathy
104. Axonal transport blockade in the neonatal rat optic nerve induces limited retinal ganglion cell death
105. Efficacy of methylprednisolone in acute spinal cord injury
106. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury
107. Current application of "high-dose" steroid therapy for CNS injury. A pharmacological perspective
108. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesvlate for 48 hours in the treatment of acute spinal cord injury
109. Steroids and spinal cord injury: Revisiting the NASCIS 2 and NASC1S 3 trials
110. The physiological relevance of glucocorticoid endangerment of the hippocampus
111. Traumatic optic neuropathy. A meta-analysis
112. The neuroprotective pharmacology of methylprednisolone
113. Inhibition of lipid peroxidation in central nervous system trauma and ischemia
114. 21-Aminosteroid lipid peroxidation inhibitor U74006F protects against cerebral ischemia in gerbils
115. 21-Aminosteroids attenuate excitotoxic neuronal injury in cortical cell cultures
116. Pretreatment with U74006F improves neurologic outcome following complete cerebral ischemia in dogs
117. Tirilazad reduces cortical infarction after transient but not permanent focal cerebral ischemia in rats
118. Effect of lipid peroxidation inhibition on retinal ganglion cell death
119. Mechanisms of optic nerve damage in primary open angle glaucoma
120. TUNEL-positive ganglion cells in human primary open-angle glaucoma
121. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma
122. Response of blood flow to warm and cold in normal and low-tension glaucoma patients
123. Migraine and low-tension glaucoma. A case-control study
124. Optic nerve blood-flow abnormalities in glaucoma
125. The response of blood flow velocity in the ophthalmic artery and blood flow of the finger to warm and cold stimuli in glaucomatous patients
126. Calcium channel blockers in the management of low-tension and open-angle glaucoma
127. 2(+)-antagonist on visual field in low-tension glaucoma
128. Neuroretinal rim area in low tension glaucoma: Effect of nifedipine and acetazolamide compared to no treatment
129. Lack of effect of calcium channel blockers on open-angle glaucoma
130. Influence of vasospasm on visual function
131. Color Doppler ultrasound analysis of ocular circulation after topical calcium channel blocker
132. HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists
133. Cytosolic free calcium during focal cerebral ischemia and the effects of nimodipine on calcium and histologic damage
134. Nitrate therapy may retard glaucomatous optic neuropathy, perhaps through modulation of glutamate receptors
135. Improvement of retinal functions after ischemia with L-arginine and its derivatives
136. Effect of chronic nitrate treatment on retinal vessel caliber in open-angle glaucoma
137. The retinal nerve fiber layer, neuroretinal rim area, and visual evoked potentials in MS
138. Retinal nerve fiber layer in multiple sclerosis
139. Risk of developing multiple sclerosis after uncomplicated optic neuritis: A long-term prospective study
140. The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial